v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
REVENUE $ 1,524,262 $ 1,322,747
COST OF REVENUE (685,992) (563,599)
GROSS PROFIT 838,270 759,148
SELLING (242,074) (162,712)
COMMISSION (73,691) (34,905)
GENERAL AND ADMINISTRATIVE (3,779,152) (3,134,874)
TOTAL OPERATING EXPENSES (4,094,917) (3,332,491)
LOSS FROM OPERATIONS (3,256,647) (2,573,343)
OTHER INCOME (EXPENSES)    
Other income, net 113,807 29,209
Interest income 3,416 67,930
Unrealized holding gain (loss) on marketable securities 8,953 (5,018)
Gain on disposal of property and equipment 112
Exchange gain, net 826,149
Loss on disposal of non-marketable securities (1,000)
TOTAL OTHER INCOME, NET 951,325 92,233
LOSS BEFORE INCOME TAXES (2,305,322) (2,481,110)
INCOME TAX EXPENSE (2,285) (4,934)
NET LOSS (2,307,607) (2,486,044)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS 27,816 15,570
NET LOSS ATTRIBUTABLE TO AGAPE ATP CORPORATION (2,279,791) (2,470,474)
OTHER COMPREHENSIVE LOSS    
Foreign currency translation adjustment (42,542) (2,363)
TOTAL COMPREHENSIVE LOSS (2,350,149) (2,488,407)
Less: Comprehensive loss attributable to non-controlling interests 29,655 15,572
COMPREHENSIVE LOSS ATTRIBUTABLE TO AGAPE ATP CORPORATION $ (2,320,494) $ (2,472,835)
LOSS PER SHARE    
Basic [1] $ (2.85) $ (31.74)
Diluted [1] $ (2.85) $ (31.74)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING*    
Basic [1] 801,081 77,839
Diluted [1] 801,081 77,839
[1] Weighted average number of common shares outstanding have been adjusted on a retroactive basis to reflect 1-for-50 reverse stock split effective on February 20, 2026.